Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-16

Clinical Trial Update: A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer [Phase 3]

View source ↗

Summary

A randomized Phase III trial comparing POF with SOX/CAPOX/FOLFOX as postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • POF

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Gastric Cancer Stage III | Phase 3 | Status: UNKNOWN